| Name | Life Science REIT |
|---|---|
| Epic | LABS |
| Isin | GB00BP5X4Q29 |
| Index | MID300 |
| Industry | Real Estate Investment Trusts |
| Latest share price | 43.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £150.50 | Debt ratio | n/a |
| Shares in issue | 350.00 | Debt-to-equity ratio | n/a |
| P/E ratio | 33.3 | Assets / equity ratio | n/a |
| Total dividends per share | 2.00p | Price to book value | n/a |
| Dividend yield | 3.2 | ROCE | -3.72 |
| Dividend cover | 0.95 | EPS growth | 171 |
| Earning per share | -6.2 | 52-week high / low | 31.50p / 68.60p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| 2nd Interim | 2024-04-04 | 2024-05-13 | 1.00p |
| Interim | 2023-09-28 | 2023-10-31 | 1.00p |
| 2nd Interim | 2023-04-13 | 2023-05-15 | 3.00p |
| Interim | 2022-09-29 | 2022-10-31 | 1.00p |
| Company name | Life Science REIT |
|---|---|
| Address | 65 Gresham Street, London, United Kingdom, EC2V 7NQ |
| Telephone | +44 (0) 207 945 9566 |
| Website | http://www.lifesciencereit.co.uk/ |
| Director | Position |
|---|---|
| Mrs Claire Boyle (née Barnes) | Non-Executive Chairman |
| Mr Richard Howell | Senior Independent Director |
| Dr Sally Ann Forsyth | Independent Non-Executive Director |
| Mr Michael Taylor | Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | n/a | n/a | n/a |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 389.71 | 394.12 | 192.17 |
| Inventory / work in progress | n/a | n/a | n/a |
| Trade and other receivables | 6.66 | 7.66 | 3.27 |
| Cash and equivalents | 14.34 | 45.61 | 165.96 |
| Other current assets and asset held for resale | n/a | 0.43 | n/a |
| Total of all assets | 410.7 | 447.83 | 361.4 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 14.44 | 50.44 | 10.82 |
| Long term liabilities | 112.52 | 77.93 | n/a |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 126.96 | 128.37 | 10.82 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 283.75 | 319.45 | 350.58 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 3.5 | 3.5 | 3.5 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -41.58 | -19.87 | 7.74 |
| Share premium account | n/a | n/a | 339.34 |
| Total equity | 283.75 | 319.45 | 350.58 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -14.59 | -26.94 | 7.73 |
| Pre-tax profit | -21.85 | -27.47 | 7.74 |